메뉴 건너뛰기




Volumn 86, Issue 2, 2009, Pages

Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon α-2b and ribavirin for chronic hepatitis C

Author keywords

Autoimmune process; Chronic hepatitis C; Graves' disease; Pegylated interferon 2b and ribavirin; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN ASPART; INSULIN DETEMIR; PEGINTERFERON ALPHA2B; RIBAVIRIN; THIAMAZOLE;

EID: 70349786423     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.08.009     Document Type: Article
Times cited : (9)

References (12)
  • 1
    • 2942587153 scopus 로고    scopus 로고
    • Interferon alpha-a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity
    • Devendra D., and Eisenbarth G.S. Interferon alpha-a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin. Immunol. 111 (2004) 225-233
    • (2004) Clin. Immunol. , vol.111 , pp. 225-233
    • Devendra, D.1    Eisenbarth, G.S.2
  • 2
    • 0030030681 scopus 로고    scopus 로고
    • Interferon-alpha and IDDM: comment
    • Foulis A.K. Interferon-alpha and IDDM: comment. Diabetologia 39 (1996) 127
    • (1996) Diabetologia , vol.39 , pp. 127
    • Foulis, A.K.1
  • 4
    • 0024498659 scopus 로고
    • Effect of interferon on glucose tolerance and insulin sensitivity
    • Koivisto V.A., Pelkonen R., and Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 38 (1989) 641-647
    • (1989) Diabetes , vol.38 , pp. 641-647
    • Koivisto, V.A.1    Pelkonen, R.2    Cantell, K.3
  • 6
    • 0041736247 scopus 로고    scopus 로고
    • Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy
    • Jabr F.I., and Ordinario M.M. Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy. Am. J. Med. 115 (2003) 158-159
    • (2003) Am. J. Med. , vol.115 , pp. 158-159
    • Jabr, F.I.1    Ordinario, M.M.2
  • 7
    • 34247159134 scopus 로고    scopus 로고
    • Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C
    • Soultati A.S., Dourakis S.P., Alexopoulou A., Deutsch M., and Archimandritis A.J. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C. World J. Gastroenterol. 13 (2007) 1292-1294
    • (2007) World J. Gastroenterol. , vol.13 , pp. 1292-1294
    • Soultati, A.S.1    Dourakis, S.P.2    Alexopoulou, A.3    Deutsch, M.4    Archimandritis, A.J.5
  • 9
    • 33646052603 scopus 로고    scopus 로고
    • Clinical review, Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening
    • Barker J.M. Clinical review, Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J. Clin. Endocrinol. Metab. 91 (2006) 1210-1217
    • (2006) J. Clin. Endocrinol. Metab. , vol.91 , pp. 1210-1217
    • Barker, J.M.1
  • 10
    • 33645986654 scopus 로고    scopus 로고
    • The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification
    • Mandac J.C., Chaudhry S., Sherman K.E., and Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 43 (2006) 661-672
    • (2006) Hepatology , vol.43 , pp. 661-672
    • Mandac, J.C.1    Chaudhry, S.2    Sherman, K.E.3    Tomer, Y.4
  • 11
    • 0030927636 scopus 로고    scopus 로고
    • Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy
    • Deutsch M., Dourakis S., Manesis E.K., Gioustozi A., Hess G., Horsch A., et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 26 (1997) 206-210
    • (1997) Hepatology , vol.26 , pp. 206-210
    • Deutsch, M.1    Dourakis, S.2    Manesis, E.K.3    Gioustozi, A.4    Hess, G.5    Horsch, A.6
  • 12
    • 0026794365 scopus 로고
    • Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis
    • Fabris P., Betterle C., Floreani A., Greggio N.A., de Lazzari F., Naccarato R., et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 340 (1992) 548
    • (1992) Lancet , vol.340 , pp. 548
    • Fabris, P.1    Betterle, C.2    Floreani, A.3    Greggio, N.A.4    de Lazzari, F.5    Naccarato, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.